ProSolvr logo

Resolve problems, permanently

Root Cause Analysis of Raw Material Quality Failures in Pharmaceutical Industry

RCA of Raw Material Quality Failures

Raw material quality failures in the pharmaceutical industry often stem from a combination of supplier issues, poor storage practices, and weak internal controls. Unqualified suppliers, especially those not audited or lacking CAPA implementation for past issues, pose a high risk to raw material integrity. When procurement processes do not include quality checks before purchase order release or rely solely on cost-based decisions, the likelihood of introducing non-compliant ingredients into the production line increases significantly.

Material handling and storage deficiencies are another major cause. Cross-contamination during storage—particularly in shared spaces with incompatible materials—can compromise batch quality. Improper storage conditions such as humidity or temperature excursions further degrade raw materials. In many cases, limited in-house testing and over-reliance on third-party results mean that quality deviations go undetected. Incomplete COA verification and test results not cross-checked against USP, EP, or JP specifications weaken compliance and quality assurance.

Effective resolution of such failures requires a structured and thorough Root Cause Analysis. ProSolvr enables quality teams to visually explore interconnected causes using Six Sigma-based fishbone diagrams. Its collaborative interface helps teams uncover root contributors like incomplete batch documentation, missing sampling logs, or unverified material traceability. This structured, layered approach moves teams from guesswork to evidence-backed conclusions, making CAPA more focused and effective.

By addressing core issues such as inadequate supplier qualification, insufficient COA checks, and documentation not aligned with cGMP, pharmaceutical companies can prevent recurring material failures. ProSolvr helps transform complex problem-solving into a visual, team-driven process that supports compliance, audit readiness, and continuous improvement. This approach not only reduces risk but also strengthens operational reliability and product safety across the value chain.

Raw Material Quality Failures

    • Supplier Issues
      • Supplier quality systems inadequate
        • No CAPA implementation for past issues
      • Unqualified supplier selected
        • Supplier not audited
    • Material Handling & Storage
      • Cross-contamination during storage
        • Shared storage with incompatible materials
      • Improper storage conditions
        • Humidity or temperature excursions
    • Inadequate Testing
      • Limited in-house quality testing
        • Reliance on third-party testing only
      • Incomplete COA verification
        • Test results not cross-checked with specifications
    • Documentation & Traceability
      • Materials not traceable to source
        • No material identification or tagging
      • Incomplete batch documentation
        • Missing test records or sampling logs
    • Procurement Process
      • Inadequate supplier qualification process
        • No audit or capability assessment
      • Lack of quality checks before PO release
        • Procurement decisions based on cost only
    • Regulatory Non-compliance
      • Documentation not aligned with cGMP
        • Batch certificates missing critical information
      • Material not meeting pharmacopeial standards
        • No verification against USP/EP/JP specs

Suggested Actions Checklist

Here are some corrective actions, preventive actions and investigative actions that organizations may find useful:

    • Supplier Issues
      • Supplier Quality Systems Inadequate
        • Corrective Actions:
          • Collaborate with the supplier to implement robust quality management systems (QMS) aligned with ICH Q10 guidelines.
        • Preventive Actions:
          • Include quality system evaluations as part of supplier qualification and periodic review processes.
        • Investigative Actions:
          • Assess past non-conformances and audit reports to identify patterns in supplier system failures.
      • Unqualified Supplier Selected
        • Corrective Actions:
          • Suspend or phase out use of unqualified suppliers and requalify using standard procedures.
        • Preventive Actions:
          • Establish a supplier qualification SOP with risk-based assessment criteria.
        • Investigative Actions:
          • Analyze procurement logs to trace how the supplier bypassed qualification protocols.
    • Material Handling & Storage
      • Cross-Contamination During Storage
        • Corrective Actions:
          • Segregate materials based on contamination risk and clean affected storage zones.
        • Preventive Actions:
          • Implement color-coded or physically partitioned storage areas.
        • Investigative Actions:
          • Review past deviation reports and environmental monitoring logs for contamination events.
      • Improper Storage Conditions
        • Corrective Actions:
          • Restore and calibrate storage environment to meet label requirements (e.g., temperature, humidity).
        • Preventive Actions:
          • Install automated alert systems for environmental excursions in storage areas.
        • Investigative Actions:
          • Analyze equipment maintenance logs and past deviation reports.
    • Inadequate Testing
      • Limited In-House Quality Testing
        • Corrective Actions:
          • Expand internal testing capabilities for critical raw material attributes.
        • Preventive Actions:
          • Invest in training and equipment for high-risk material categories.
        • Investigative Actions:
          • Review historical complaints linked to undetected defects due to testing gaps.
      • Incomplete COA Verification
        • Corrective Actions:
          • Re-verify certificates of analysis for incoming raw materials against defined specs.
        • Preventive Actions:
          • Implement COA verification checklist as part of incoming goods inspection.
        • Investigative Actions:
          • Audit previous COA records and identify approval lapses or omissions.
    • Documentation & Traceability
      • Materials Not Traceable to Source
        • Corrective Actions:
          • Trace and quarantine non-traceable materials and flag them for non-conformance.
        • Preventive Actions:
          • Implement barcode or RFID-based traceability systems.
        • Investigative Actions:
          • Perform audit trails to locate documentation or identify process gaps.
      • Incomplete Batch Documentation
        • Corrective Actions:
          • Rectify missing fields and initiate deviation reports where applicable.
        • Preventive Actions:
          • Conduct routine checks and implement document control workflows.
        • Investigative Actions:
          • Analyze training records and identify gaps in documentation practices.
    • Procurement Process
      • Inadequate Supplier Qualification Process
        • Corrective Actions:
          • Revise qualification process to include GMP, capacity, and risk assessments.
        • Preventive Actions:
          • Create a standardized checklist for all new supplier approvals.
        • Investigative Actions:
          • Evaluate how previous suppliers were qualified and pinpoint oversight.
      • Lack of Quality Checks Before PO Release
        • Corrective Actions:
          • Put temporary hold on new POs until a quality review gate is installed.
        • Preventive Actions:
          • Implement cross-functional PO approval systems with mandatory QA sign-off.
        • Investigative Actions:
          • Examine purchase request workflows to see where QA inputs were bypassed.
    • Regulatory Non-Compliance
      • Documentation Not Aligned with cGMP
        • Corrective Actions:
          • Revise all non-compliant documents to reflect cGMP structure and terminology.
        • Preventive Actions:
          • Conduct regular training on regulatory documentation standards.
        • Investigative Actions:
          • Perform gap analysis comparing existing documents with cGMP expectations.
      • Material Not Meeting Pharmacopeial Standards
        • Corrective Actions:
          • Reject or recall non-conforming material and notify the supplier.
        • Preventive Actions:
          • Include pharmacopeial compliance as a release criterion for each lot.
        • Investigative Actions:
          • Review supplier’s test methods and internal release criteria.
 

Who can learn from the Raw Materials Quality Failures template?

  • Quality Assurance (QA) Teams: QA teams can use the findings from the RCA to strengthen their internal quality controls and improve compliance monitoring practices. It enables them to better align procedures with regulatory expectations and prevent future lapses.
  • Regulatory Affairs Professionals: By analyzing where documentation or compliance issues occurred, regulatory professionals can refine their processes to ensure readiness for audits and inspections. It also helps in preparing more robust responses to regulatory authorities.
  • Procurement and Vendor Management Teams: These teams can use the RCA insights to enhance supplier selection, auditing, and evaluation practices. It reinforces the importance of quality over cost and builds a more reliable supplier base.
  • Manufacturing and Operations Managers: The RCA helps operations teams identify where procedural breakdowns have occurred and adjust workflows accordingly. This supports more consistent production outcomes and reduces operational risks.
  • Research and Development (R&D) Teams: R&D can learn how upstream material or process flaws impact product performance and quality. This understanding can guide better material specifications and process design during development.
  • Training and Human Resources (HR) Departments: Training teams can use the RCA to identify skill gaps and target training interventions more effectively. HR can integrate these insights into competency development and performance assessments.

Why use this template?

Applications like ProSolvr, which incorporate GEN-AI to build and analyze fishbone diagrams, significantly elevate the efficacy of root cause analysis. By allowing users to map various causes into an interactive, visual diagram, ProSolvr facilitates clearer understanding and communication among cross-functional teams. Once the root causes are identified, the platform can assist organizations in generating structured CAPA plans tied directly to those causes, ensuring that actions are strategically preventive.

ProSolvr's strength lies in its ability to provide a guided analytical path. Pharmaceutical companies can use ProSolvr to ensure continuous improvement throughout the organization.

Use ProSolvr by smartQED for effectively rooting out problems in your organization.

Curated from community experience and public sources:

  • https://www.spendedge.com/blogs/problems-pharmaceutical-raw-materials/
  • https://www.linkedin.com/pulse/impact-raw-material-quality-final-pharmaceutical-altair-lifescience-r9dff/